Shortage outlook · all drugs · read October 2026
How long has Bupivacaine Hydrochloride been on the FDA shortage list?
Bupivacaine Hydrochloride has been on the FDA shortage list for 8 years and 8 months. 13 of the 397 listings measured since 2014 lasted at least that long. Only 13 past listings reached this age, too few to show a share. The counts are below. These are counts of listings, not a forecast.
Compiled by Vincent Wesley Couey (ORCID 0009-0005-6869-308X). FDA list read October 2026.
Bupivacaine Hydrochloride has been on the FDA shortage list for 8 years and 8 months (March 2018 to October 2026).
- 13 of the 397 listings measured since 2014 lasted at least that long.
- Only 13 past listings reached this age, too few to show a share. The counts are below.
- Bupivacaine Hydrochloride has been listed 2 times since 2014: earlier listings lasted 1 year and 3 months.
- None of this predicts an end date. A listing ends when the FDA removes it, which reflects supply across the whole country, and says nothing about one pharmacy's shelf.
The listing history, to scale
- Bupivacaine Hydrochloride InjectionListed June 2014 to August 2015 · 1 year and 3 months · already listed when the archive began
- Bupivacaine Hydrochloride InjectionListed since March 2018 · 8 years and 8 months
What past listings of this age did
Of past listings that had already run 8 years and 8 months, how many were still listed later?
What the FDA list says about it today
Reasons companies gave: other (6), discontinuation of the manufacture of the drug (5), demand increase for the drug (2) and delay in shipping of the drug (1); 43 of 57 gave none. FDA category: Anesthesia.
Company by company
Of 57 presentations, the companies reported 43 available, 5 with limited availability and 9 unavailable. This is each company's own report to the FDA, with the date of its last update.
- Somerset Therapeutics, LLC6 presentations · last updated 27 October 2026
- Fresenius Kabi USA, LLC10 presentations · last updated 3 November 2026
- Hospira, Inc., a Pfizer Company20 presentations · last updated 9 November 2026
- Huons Co., Ltd1 presentation · last updated 2 November 2026
- Eugia US LLC8 presentations · last updated 19 October 2026
- Aspiro Pharma Limited6 presentations · last updated 17 July 2026
- Kindos Pharmaceuticals Co. Ltd.5 presentations · last updated 5 May 2026
- ONESOURCE SPECIALTY PTE LTD1 presentation · last updated 18 September 2026
FDA shortage list read October 2026 (monthly archived copies since 2014, rebuilt in the published dataset; current listing file read 11 November 2026). Listing is the FDA's status, not a statement about any pharmacy.
Where can you go from this result?
This result is one of 61 drugs on the list now. Open it in the lookup to search another drug, or read how the listings were measured.
- Bupivacaine Hydrochloride, Epinephrine Bitartrate104 months
- Ketorolac Tromethamine103 months
- Ropivacaine Hydrochloride103 months
- Lorazepam102 months
To check what is available now, ask your pharmacist, and see FDA drug shortage information and the FDA drug shortages database.